COUGH is the #3 most commonly reported adverse reaction for CEFPROZIL, manufactured by Ascend Laboratories, LLC. There are 61 FDA adverse event reports linking CEFPROZIL to COUGH. This represents approximately 2.6% of all 2,368 adverse event reports for this drug.
Patients taking CEFPROZIL who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
COUGH61 of 2,368 reports
COUGH is a less commonly reported adverse event for CEFPROZIL, but still significant enough to appear in the safety profile.
Other Side Effects of CEFPROZIL
In addition to cough, the following adverse reactions have been reported for CEFPROZIL:
COUGH has been reported as an adverse event in 61 FDA reports for CEFPROZIL. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is COUGH with CEFPROZIL?
COUGH accounts for approximately 2.6% of all adverse event reports for CEFPROZIL, making it one of the most commonly reported side effect.
What should I do if I experience COUGH while taking CEFPROZIL?
If you experience cough while taking CEFPROZIL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.